Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease

被引:112
作者
Pirmoazen, Amir M. [1 ]
Khurana, Aman [2 ]
El Kaffas, Ahmed [3 ]
Kamaya, Aya [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiol, Stanford, CA 94305 USA
[2] Univ Kentucky, Dept Radiol, Lexington, KY USA
[3] Stanford Univ, Sch Med, Dept Radiol, Mol Imaging Program Stanford, Stanford, CA 94305 USA
来源
THERANOSTICS | 2020年 / 10卷 / 09期
基金
美国国家卫生研究院;
关键词
nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; quantitative ultrasound; noninvasive assessment; hepatic steatosis; CONTROLLED ATTENUATION PARAMETER; ACOUSTIC STRUCTURE QUANTIFICATION; DUAL-ENERGY CT; SOUND SPEED; TRANSIENT ELASTOGRAPHY; IN-VIVO; NONINVASIVE DIAGNOSIS; HEPATORENAL INDEX; SPECTRUM ANALYSIS; FIBROSIS SCORE;
D O I
10.7150/thno.40249
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Nonalcoholic fatty liver disease is a major global health concern with increasing prevalence, associated with obesity and metabolic syndrome. Recently, quantitative ultrasound-based imaging techniques have dramatically improved the ability of ultrasound to detect and quantify hepatic steatosis. These newer ultrasound techniques possess many inherent advantages similar to conventional ultrasound such as universal availability, real-time capability, and relatively low cost along with quantitative rather than a qualitative assessment of liver fat. In addition, quantitative ultrasound-based imaging techniques are less operator dependent than traditional ultrasound. Here we review several different emerging quantitative ultrasound-based approaches used for detection and quantification of hepatic steatosis in patients at risk for nonalcoholic fatty liver disease. We also briefly summarize other clinically available imaging modalities for evaluating hepatic steatosis such as MRI, CT, and serum analysis.
引用
收藏
页码:4277 / 4289
页数:13
相关论文
共 118 条
  • [21] Ultrasonography to Quantify Hepatic Fat Content: Validation by 1H Magnetic Resonance Spectroscopy
    Edens, Mireille A.
    van Ooijen, Peter M. A.
    Post, Wendy J.
    Haagmans, Mark J. F.
    Kristanto, Wisnumurti
    Sijens, Paul E.
    van der Jagt, Erik J.
    Stolk, Ronald P.
    [J]. OBESITY, 2009, 17 (12) : 2239 - 2244
  • [22] Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
    Estes, Chris
    Anstee, Quentin M.
    Teresa Arias-Loste, Maria
    Bantel, Heike
    Bellentani, Stefano
    Caballeria, Joan
    Colombo, Massimo
    Craxi, Antonio
    Crespo, Javier
    Day, Christopher P.
    Eguchi, Yuichiro
    Geier, Andreas
    Kondili, Loreta A.
    Kroy, Daniela C.
    Lazarus, Jeffrey V.
    Loomba, Rohit
    Manns, Michael P.
    Marchesini, Giulio
    Nakajima, Atsushi
    Negro, Francesco
    Petta, Salvatore
    Ratziu, Vlad
    Romero-Gomez, Manuel
    Sanyal, Arun
    Schattenberg, Joern M.
    Tacke, Frank
    Tanaka, Junko
    Trautwein, Christian
    Wei, Lai
    Zeuzem, Stefan
    Razavi, Homie
    [J]. JOURNAL OF HEPATOLOGY, 2018, 69 (04) : 896 - 904
  • [23] Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
    Estes, Chris
    Razavi, Homie
    Loomba, Rohit
    Younossi, Zobair
    Sanyal, Arun J.
    [J]. HEPATOLOGY, 2018, 67 (01) : 123 - 133
  • [24] Cytokeratin-18 Fragment Levels as Noninvasive Biomarkers for Nonalcoholic Steatohepatitis: A Multicenter Validation Study
    Feldstein, Ariel E.
    Wieckowska, Anna
    Lopez, A. Rocio
    Liu, Yao-Chang
    Zein, Nizar N.
    McCullough, Arthur J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 1072 - 1078
  • [25] A new method for attenuation coefficient measurement in the liver - Comparison with the spectral shift central frequency method
    Fujii, Y
    Taniguchi, N
    Itoh, K
    Shigeta, K
    Wang, Y
    Tsao, JW
    Kumasaki, K
    Itoh, T
    [J]. JOURNAL OF ULTRASOUND IN MEDICINE, 2002, 21 (07) : 783 - 788
  • [26] Feasibility study of ultrasonic fatty liver biopsy:texture vs. attenuation and backscatter
    Gaitini, D
    Baruch, Y
    Ghersin, E
    Veitsman, E
    Kerner, H
    Shalem, B
    Yaniv, G
    Sarfaty, C
    Azhari, H
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2004, 30 (10) : 1321 - 1327
  • [27] Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients
    Garg, Harshit
    Aggarwal, Sandeep
    Shalimar
    Yadav, Rajni
    Gupta, Siddhartha Datta
    Agarwal, Lokesh
    Agarwal, Samagra
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2018, 14 (01) : 81 - 92
  • [28] EX VIVO STUDY OF QUANTITATIVE ULTRASOUND PARAMETERS IN FATTY RABBIT LIVERS
    Ghoshal, Goutam
    Lavarello, Roberto J.
    Kemmerer, Jeremy P.
    Miller, Rita J.
    Oelze, Michael L.
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2012, 38 (12) : 2238 - 2248
  • [29] Inter-platform reproducibility of ultrasonic attenuation and backscatter coefficients in assessing NAFLD
    Han, Aiguo
    Zhang, Yingzhen N.
    Boehringer, Andrew S.
    Andre, Michael P.
    Erdman, John W., Jr.
    Loomba, Rohit
    Sirlin, Claude B.
    O'Brien, William D., Jr.
    [J]. EUROPEAN RADIOLOGY, 2019, 29 (09) : 4699 - 4708
  • [30] Repeatability and Reproducibility of the Ultrasonic Attenuation Coefficient and Backscatter Coefficient Measured in the Right Lobe of the Liver in Adults With Known or Suspected Nonalcoholic Fatty Liver Disease
    Han, Aiguo
    Andre, Michael P.
    Deiranieh, Lisa
    Housman, Elise
    Erdman, John W., Jr.
    Loomba, Rohit
    Sirlin, Claude B.
    O'Brien, William D., Jr.
    [J]. JOURNAL OF ULTRASOUND IN MEDICINE, 2018, 37 (08) : 1913 - 1927